Surgical approaches for stage Ⅰ and Ⅱ thymoma-associated myasthenia gravis:feasibility of complete video-assisted thoracoscopic surgery (VATS) thymectomy in comparison with trans-sternal resection

Complete resection could be achieved in virtually all myasthenic patients with Masaoka stage I and II thymoma us- ing the trans-sternal technique. Whether this is appropriate for minimally invasive approach is not yet clear. We evalu- ated the feasibility of complete video-assisted thoracoscopic surgery （VATS） thymectomy for the treatment of Ma- saoka stage I and Ⅱ thymoma-associated myasthenia gravis, compared to conventional trans-sternal thymectomy. We summarized 33 patients with Masaoka stage I and II thymoma-associated myasthenia gravis between April 2006 and September 2011. Of these, 15 patients underwent right-sided complete VATS （the VATS group） by us- ing adjuvant pneuomomediastinum, comparing with 18 patients using the trans-sternal approach （the T3b group）. No intraoperative death was found and no VATS case required conversion to median sternotomy. Significant differences between the two groups regarding duration of surgery and volume of intraoperative blood loss （P = 0.001 and P 〈 0.001, respectively） were observed. Postoperative morbidities were 26.7% and 33.3% for the VATS and T3b groups, respectively. All 33 patients were followed up for 12 to 61 months in the study. The cumulative probabilities of reaching complete stable remission and effective rate were 26.7% （4/15） and 93.3% （14/15） in the VATS group, which had a significantly higher complete stable remission and effective rate than those in the T3b group （P = 0.026 and P = 0.000, respectively）. We conclude that VATS thymectomy utilizing adjuvant pneuomo- mediastinum for the treatment of stage I and II thymoma-associated myasthenia gravis is technically feasible but deserves further investigation in a large series with long-term follow-up.

Nonintubated uniportal video-assisted thoracoscopic surgery for primary spontaneous pneumothorax

Objective： The objective of the current study was to evaluate the feasibility and safety of nonintubated nniportal video-assisted thoracoscopic surgery （VATS） for the management of primary spontaneous pneumothorax （PSP）. Methods： From November 2011 to June 2013, 32 consecutive patients with PSP were treated by nonintubated uniportal thoracoscopic bullectomy using epidnral anaesthesia and sedation without endotracheal intubation. An incision 2 cm in length was made at the 6th intercostal space in the median axillary line. The pleural space was entered by blunt dissection for placement of a soft incision protector. Instruments were then inserted through the incision protector to perform thoracoscopic bullectomy. Data were collected within a minimum follow-up period of 10 months. Results： The average time of surgery was 49.0 rain （range, 33-65 rain）. No complications were recorded. The postoperative feeding time was 6 h. The mean postoperative chest tube drainage and hospital stay were 19.3 h and 41.6 h, respectively. The postoperative pain was mild for 30 patients （93.75%） and moderate for two patients （6.25%）. No recurrences ofpneumothorax were observed at follow-up. Conclusions： The initial results indicated that nonintubated uniportal video-assisted thoracoscopic operations are not only technically feasible, but may also be a safe and less invasive alternative for select patients in the management of PSP. This is the first report to include the use of a nonintubated uniportal technique in VATS for such a large number of PSP cases. Further work and development of instruments are needed to define the applications and advantages of this technique.

Safety and feasibility of video-assisted thoracoscopic surgery for stage IIIA lung cancer

Objective： The current study was prospectively designed to explore the application of video-assisted thoracoscopic surgery （VATS） radical treatment for patients with stage ⅢA lung cancer, with the primary endpoints being the safety and feasibility of this operation and the second endpoints being the survival and complications after the surgery. Methods： A total of 51 patients with radiologically or mediastinoscopically confirmed stage ⅢA lung cancer underwent VATS radical treatment, during which the standard pulmonary lobectomy and mediastinal lymph node dissection were performed after pre-operative assessment. The operative time, intraoperative blood loss/ complications, postoperative recovery, postoperative complications, and lymph node dissection were recorded and analyzed. This study was regarded as successful if the surgical success rate reached 90% or higher. Results： A total of 51 patients with non-small cell lung cancer （NSCLC） were enrolled in this study from March 2009 to February 2010. The median post-operative follow-up duration was 50.5 months. Of these 51 patients, 41 （80.4%） had N2 lymph node metastases. All patients underwent the thoracoscopic surgeries, among whom 50 （98%） received pulmonary lobectomy and mediastinal lymph node dissection completely under the thoracoscope, 6 had their incisions extended to about 6 cm due to larger tumor sizes, and 1 had his surgery performed using a 12 cm small incision for handling the adhesions between lymph nodes and blood vessels. No patient was converted to conventional open thoracotomy. No perioperative death was noted. One patient received a second surgery on the second post-operative day due to large drainage （〉1,000 mL）, and the postoperative recovery was satisfactory. Up to 45 patients （88.2%） did not suffer from any perioperative complication, and 6 （11.8%） experienced one or more complications. Conclusions： VATS radical treatment is a safe and feasible treatment for stage ⅢA lung cancer.

A single institution experience using the LigaSure vessel sealing system in video-assisted thoracoscopic surgery for primary spontaneous pneumothorax

This study sought to report our 6-year experience with the LigaSure vessel sealing system（LVSS） in videoassisted thoracoscopic surgery（VATS） for primary spontaneous pneumothorax.A series of 180 consecutive patients with primary spontaneous pneumothorax were operated on in our institution from May 2005 to December 2010.Intraoperatively,large lesions（bullae or blebs） with a diameter more than 2 cm were resected by staplers,and the residual lesions were treated by LVSS.LVSS was also used to ablate the apical area when no lesions were found.Conventional apical pleural abrasion was done in all cases.All patients were successfully treated using VATS with minimal perioperative bleeding.The mean operating time was 76 minutes（range,43-160 minutes） for single-side procedures and 169 minutes（range,135-195 minutes） for bilateral procedures,the mean number of applied staples was 1.93 per patient（range,0-8 days）,the duration of drainage was 3.8 days（range,2-15 days）,and the duration of hospital stay was 5.8 days（range,3-16 days）.Postoperative complications included persistent air leak（〉 5 days） in 11 cases（6.1%） and residual pneumothorax in 6（3.3%）.None required reoperation.The mean duration of follow-up was 57 months（range,24-105 months）.Recurrence was seen in three cases（1.7%）,and all underwent another operation thereafter.None of the lesions in the relapse cases received ablation with LVSS in the first operation.LVSS can optimize VATS for primary spontaneous pneumothorax and reduces the use of single-use staples.The method is safe,easy to use,and cost-effective and produces satisfactory results.

Middle lobe torsion after right upper and lower lobectomy:repositioning of lobar torsion using a3-cm uniportal video-assisted thoracoscopic surgery

We aimed to describe a method for repositioning of right middle lobar torsion by using a 3-cm uniportal video-assisted thoracoscopic surgery(VATS) approach. Middle lobe torsion occurred after right upper and lower lobectomy in a 74-year-old man. Immediate re-exploratory thoracotomy using the 3-cm uniportal VATS approach was performed. The torsion was corrected, and the lobe was anchored to the anterior chest wall with Prolene stitches. The patient recovered well postoperatively with daily improvements in chest radiographic findings. Follow-up examination was performed using fiberbronchoscopy, which revealed an unobstructed right middle lobe bronchus and sticky yellow sputum. Follow-up chest computed tomography was performed 3 months after the primary surgery and revealed increased expansion of the right middle lobe. We repositioned the right middle lobe successfully by using the 3-cm uniportal VATS approach, but more cases are needed to confirm the feasibility of the approach. Lobectomy remains the primary treatment option for such cases.

Long-term survival outcomes of video-assisted thoracic surgery for patients with non-small cell lung cancer

Background： Video-assisted thoracic surgery （VATS） has been shown to be a safe alternative to conventional thoracotomy for patients with non-small cell lung cancer （NSCLC）. However, popularization of this relatively novel technique has been slow, partly due to concerns about its long-term outcomes. The present study aimed to evaluate the long-term survival outcomes of patients with NSCLC after VATS, and to determine the significant prognostic factors on overall survival. Methods： Consecutive patients diagnosed with NSCLC referred to one institution for VATS were identified from a central database. Patients were treated by either complete-VATS or assisted-VATS, as described in previous studies. A number of baseline patient characteristics, clinicopathologic data and treatment-related factors were analyzed as potential prognostic factors on overall survival. Results： Between January 2000 and December 2007, 1,139 patients with NSCLC who underwent VATS and fulfilled a set of predetermined inclusion criteria were included for analysis. The median age of the entire group was 60 years, with 791 male patients （69%）. The median 5-year overall survival for Stage Ⅰ, Ⅱ, Ⅲ and Ⅳ disease according to the recently updated TNM classification system were 72.2%, 47.5%, 29.8% and 28.6%, respectively. Female gender, TNM stage, pT status, and type of resection were found to be significant prognostic factors on multivariate analysis. Conclusions： VATS offers a viable alternative to conventional open thoracotomy for selected patients with clinically resectableNSCLC

Completely video-assisted thoracoscopic lobectomy versus open lobectomy for non-small cell lung cancer greater than 5 cm：a retrospective study

Background Completely video-assisted thoracoscopic Iobectomy is a reasonable treatment for early-stage non-small-cell lung cancer （NSCLC）.At present,the indication for this procedure is stage la and Ib peripheral lung cancer （（〈-）5 cm）; however,for larger tumors,it remains controversial whether this surgical technique is comparable to open Iobectomy.This study aimed to evaluate the safety,completeness,and efficacy of thoracoscopic Iobectomy,and to compare this technique with open Iobectomy for the treatment of non-small-cell lung cancer when the tumor＇s diameter was greater than 5 cm.Methods From May 2001 to April 2011,802 patients underwent a Iobectomy for treatment of non-small-cell lung cancer at our center.In 133 patients,the tumor was 〉 5 cm.There were 98 men and 35 women,median age 63 years （range：29-81 years）.We divided the patients into two groups,group V （completely video-assisted thoracoscopic surgery）,and group T （open Iobectomy）,and evaluated the two groups for age,gender,tumor size,pathological type,location,duration of surgery,blood loss,lymph node dissection,pathological stage,time of drainage,hospitalization,complications,overall survival and recurrence.Results There were 46 cases in group V and 87 cases in group T.Age,gender,tumor size,location,pathological type and stage were similar between the two groups.Group V had shorter operative duration （（186.5±62.8） minutes vs.（256.7±67.5） minutes,P 〈0.001） and reduced bleeding （（218.5±174.6） ml vs.（556.9±187.2） ml,P 〈0.001）.There were no significant differences between the two groups in complications,lymph node dissection,time of drainage and hospitalization.The recurrence between the two groups was equivalent （2.4% vs.3.8%,P=0.670）.The overall survival at 1,2 and 3 years was 95.1%,81.6% and 69.6% for group V and 88.3%,78.8% and 64.0% for group T.Kaplan-Meier survival curves showed that there was no significant differences between the two groups （P=0.129）.Conclusions Completely video-assisted thoracoscopic lobectomy was similar to open lobectomy in safety,completeness,and efficacy,but had a shorter operative duration,and reduced bleeding.This is a minimally invasive procedure that is feasible for a subset of non-small-cell lung cancer patients with tumor size 〉 5 cm.

CVATS与VAMT治疗非小细胞肺癌的临床效果研究

目的探讨全电视胸腔镜手术(CVATS)治疗非小细胞肺癌的临床效果。方法选取NSCLC患者58例作为研究对象,随机平均分为CVATS组和胸腔镜辅助小切口(VAMT)组,观察治疗效果。结果 CVATS组住院时间、疼痛程度以及并发症3项指标均显著低于VAMT组,P<0.05;而手术时间、术中出血量、清扫淋巴结数目、术后胸腔引流量、1年内肿瘤复发例数以及1年生存率6项指标,两组相比差异无统计学意义,P>0.05。结论相比于VAMT,CVATS可减轻患者术后疼痛,住院时间短,在治疗NSCLC中值得广泛的临床应用。

腋下小切口肺叶切除与cVATS治疗原发性肺癌患者的临床疗效

目的分析原发性肺癌患者行腋下小切口肺叶切除与完全电视胸腔镜手术(cVATS)的临床疗效。方法选取我院收治的原发性肺癌患者118例,随机将其分为观察组与对照组,各59例。观察组患者行cVATS治疗,对照组患者行腋下小切口肺叶切除治疗。比较两组患者的围术期指标、术后疼痛情况及术后并发症的发生率。结果观察组患者的切口长度、术中出血量、术后当天引流量、术后疼痛评分均显著优于对照组(P<0.05);观察组术后卧床、置管、住院时间及止疼药物使用时间均显著短于对照组(P<0.05);两组并发症总发生率比较,差异无统计学意义(P>0.05)。结论与腋下小切口肺叶切除术相比,cVATS对原发性肺癌患者的临床疗效更显著,值得在临床推广使用。

CVATS、VAMT、传统开胸手术治疗肺癌的近期临床疗效分析

目的:对比分析全电视胸腔镜手术(CVATS)、胸腔镜辅助下小切口手术(VAMT)、传统开胸手术治疗肺癌的近期临床疗效。方法:根据手术方式不同,将160例早期肺癌患者分为CVATS组(n=58)、VAMT组(n=54)及开胸组(n=48),评估3组患者近期治疗效果。结果:3组患者淋巴结清扫数目、术后半年内局部复发率比较,差异无统计学意义(P>0.05);手术时间比较,开胸组<CVATS组<VAMT组(P<0.05);术中出血量、引流时间、术后住院时间比较,VAMT组<CVATS组<开胸组(P<0.05)。术后第1天、第3天的视觉模拟疼痛(VAS)评分比较,VAMT组<CVATS组<开胸组(P<0.05);术后第7天,3组患者VAS评分比较,差异无统计学意义(P>0.05);止痛药物时间比较,VAMT组<CVATS组<开胸组(P<0.05)。CVATS组、VAMT组术后并发症发生率明显低于开胸组(P<0.05)。3组术后用力肺活量(FVC)、第1秒用力肺活量(FEV1)、最大通气量(MVV)均较术前明显下降(P<0.05),但CVATS组及VAMT组的FVC、FEV1、MVV均高于开胸组(P<0.05)。结论:CVATS、VAMT及传统开胸手术均能达到肺癌根治手术要求,但CVATS、VAMT在促进术后恢复、缓解疼痛、减少并发症及控制通气功能损伤方面均优于传统开胸手术,且CVATS优于VAMT。

完全电视胸腔镜手术(cVATS)与腋下小切口肺叶切除术治疗肺癌的临床效果对比

目的探讨完全电视胸腔镜手术(c VATS)与腋下小切口肺叶切除术治疗肺癌的临床效果。方法选取早期非小细胞肺癌患者80例,按照手术方式分为完全电视胸腔镜肺叶切除术组(观察组)60例,腋下小切口肺叶切除术组(对照组)20例。统计2组患者手术时间、淋巴结清扫数目、术中出血量、切口长度、术后卧床时间、术后24和48 h引流量、术后留置引流管时间、术后住院天数。同时记录术后并发症和疼痛及止疼药物使用。结果观察组术中出血量、切口长度、术后置管时间、术后住院天数、术后疼痛评分和止痛药物使用时间显著低于对照组,差异有统计学意义(P<0.05)。感染发生率在2组比较无统计学差异(P>0.05)。结论完全电视胸腔镜肺叶切除术具有降低创伤和出血量,减少术后患者疼痛的优点,是1种值得推荐的治疗肺癌的方式。

Comparative study of video-assisted thoracoscopic surgery ablation and radiofrequency catheter ablation on treating paroxysmal atrial fibrillation： a randomized, controlled short-term trial

Background It is unclear whether the effect of video-assisted thoracoscopic surgery ablation is better than catheter ablation on paroxysmal atrial fibrillation （PAF） or not. This study aimed to compare the effects of catheter ablation and video-assisted thoracoscopic surgery ablation on PAF. Methods From March 2008 to March 2012, 138 consecutive patients with PAF were randomly assigned to receive either video-assisted thorecoscopic surgery ablation （thoracoscopy group, n=66） or the traditional catheter ablation （catheter group, n=72）. Results No patient died during the study and all were successfully followed and included in analysis. There were no significant differences in clinical and echocardiographic characteristics between the two groups. All patients were evaluated at 1 week, 1 month, 3 months, 6 months, and 12 months after discharge by physical examination and related laboratory tests. Preoperative left atrium dimensions （LADs） of the recurrent AF were （47±4） mm in the thoracoscopy group and （46±8） mm in the catheter group, whereas the LADs were （40±5） and （39±9） mm, respectively, in non-recurrent PAF. Conclusions The short-term outcome of video-assisted thoracoscopic surgery ablation is safe and effective; and the indications are wider than those for catheter ablation. The larger left atrium diameter is related to the recurrence of atrial fibrillation. Chin Med J 2014;127 （14）： 2567-2570

单操作孔电视胸腔镜肺癌根治术治疗非小细胞肺癌患者的疗效观察

目的观察单操作孔电视胸腔镜(VATS)肺癌根治术对非小细胞肺癌(NSCLC)血管内皮生长因子受体2(VEGFR2)、胸苷激酶1(TK1)水平的影响。方法我院收治的245例NSCLC患者,按手术方式分为对照组(三孔胸腔镜肺癌根治术,n=115)和观察组(单操作孔VATS肺癌根治术,n=130),比较两组围术期指标、视觉模拟(VAS)评分、肺功能、炎性因子、肿瘤标志物、VEGFR2、TK1水平及并发症。结果观察组术中出血量较对照组少(P<0.05);术后,观察组VAS评分、炎性因子、肿瘤标志物和VEGFR2、TK1水平低于对照组,肺功能高于对照组(P<0.05)。结论单操作孔VATS肺癌根治术治疗NSCLC出血量少、疼痛轻,可改善肺功能,降低炎性因子、肿瘤标志物和VEGFR2、TK1水平,且不增加术后并发症,值得临床推广。

ERAS理念下达芬奇机器人与单孔胸腔镜肺叶切除术患者术后康复和疼痛的对比研究

目的:对比分析加速康复外科(ERAS)理念下达芬奇机器人辅助胸腔镜手术(RATS)与单孔胸腔镜手术(VATS)患者术后康复和疼痛情况。方法:回顾性分析2021年9月—2022年8月在聊城市人民医院行RATS和单孔VATS的68例患者的临床资料,其中RATS组33例,单孔VATS组35例。两组患者均在ERAS理念下实施多模式镇痛(MMA)管理方案,椎旁神经阻滞(PVB)联合静吸复合全麻,侧卧位下实施手术,术后急性疼痛服务(APS)小组进行两次/天疼痛查房。比较两组患者的一般资料、手术时间、术中镇痛药物用量、术后入麻醉后恢复室(PACU)、术后24 h、48 h和72 h患者的镇痛药物用量、恶心呕吐发生率、术后24 h、48 h和72 h的静息和咳嗽疼痛评分,胸腔引流管的平均拔除时间、术后出院时间和首次下床活动时间。结果:两组患者均顺利完成手术,无中转开胸。RATS组手术时间和麻醉时间长于VATS组;两组患者术后24 h内的静息痛和咳嗽痛评分差异无统计学意义(P>0.05),但RATS组患者术后48 h和72 h的静息痛和咳嗽痛评分低于单孔VATS组,且差异有统计学意义(P<0.05)。RATS组患者术后48h、72h阿片类药物用量低于单孔VATS组,差异有统计学意义(P<0.05)。两组患者术后首次下床活动时间、胸腔引流管拔除时间、出院时间和术后麻醉并发症相比,差异无统计学意义(P>0.05)。结论:基于ERAS理念实施MMA,RATS和单孔VATS有相似的围术期安全性和可靠性,但RATS手术时间、麻醉时间长于单孔VATS组,RATS术后48和72 h内静息、咳嗽疼痛评分和阿片药物用量低于单孔VATS组。

加速肺萎陷技术在胸腔镜手术中的应用进展

视频辅助胸腔镜手术(VATS)具有视野清晰、对呼吸生理影响小、术后疼痛轻和加速康复等优点,在临床上日渐普及。非通气侧肺萎陷是胸科手术重要环节,萎陷不良将影响手术视野并延缓手术进程,因此高质量肺萎陷是手术成功的基础。如何短时间内获得良好的肺萎陷质量已成为麻醉科医师关注的焦点。近年来,已有多种加速肺萎陷技术应用于临床,本文就非通气侧加速肺萎陷技术的应用进展进行综述,并介绍适用临床技术及其注意事项,旨在为临床实践提供参考。

肺结节定位方式研究进展

随着低剂量螺旋CT的普及和CT分辨率的提高,肺结节尤其是较小的肺结节的检出率明显提高。罹患恶性肿瘤的风险随着肺结节的增大而增加,对此,临床常选择手术切除,而电视辅助胸腔镜手术(video-assisted thoracoscopic surgery,VATS)是首选的外科手术方式。肺结节精准定位是VATS成功的关键,也是当前胸外科医生面临的重要问题。目前,较为常用的定位手段有CT引导下经皮穿刺定位、支气管镜引导下定位、术中超声定位、增强现实和3D打印辅助定位等。该文综述近年肺结节定位方法的研究进展、优缺点等,以期为临床应用和后续发展提供借鉴。

胸腔镜术前CT导引下不同路径钩丝定位≤10 mm肺磨玻璃结节比较研究

目的比较电视辅助胸腔镜手术(VATS)前CT导引下不同路径钩丝定位≤10 mm肺磨玻璃结节的安全性和有效性。方法回顾性分析2018年7月至2023年3月在绵阳市第三人民医院接受VATS前CT导引下钩丝定位的128例≤10 mm肺磨玻璃结节患者临床资料。根据定位路径将患者分为垂直组(88例)和非垂直组(40例)。记录两组穿刺针数、定位手术持续时间、穿刺成功率、VAST手术时间、穿刺相关并发症等。结果两组患者性别、年龄、吸烟史、结节部位、穿刺体位、结节大小、结节密度特征、肺气肿情况、胸膜至病灶深度比较差异无统计学意义(均P>0.05)。垂直组与非垂直组相比,穿刺针数较少、定位手术持续时间较短、气胸发生率较低、VATS手术时间较短,差异有统计学意义(均P<0.05)。被肋骨遮挡肺结节亚组分析也得出同样结果。二元logistic回归分析显示,非垂直穿刺、穿刺针数是气胸发生的独立危险因素。结论VAST术前CT导引下钩丝定位法定位≤10 mm肺磨玻璃结节安全有效。在确保病灶定位于2.0 cm范围内并有效避开肋骨、血管等遮挡情况下,优先选择垂直于胸膜进针可有效降低气胸发生率、缩短VAST手术时间。

经剑突入路达芬奇机器人手术与电视胸腔镜手术治疗前纵隔肿瘤疗效比较

目的比较经剑突入路达芬奇机器人手术与电视胸腔镜手术(VATS)治疗前纵隔肿瘤疗效。方法招募2020年1月至2023年1月广西壮族自治区人民医院收治的前纵隔肿瘤患者56例,根据手术方法不同分为机器人辅助胸腔镜手术(RATS)组(n=20例)和VATS组(n=36例),均经剑突入路。比较两组手术时间、术中出血量、48 h引流量、引流管留置时间、住院总费用,以及术后住院时间、视觉模拟量表(VAS)评分、并发症发生情况。结果VATS组有1例患者因无名静脉紧密粘连于胸腺和1例患者因胸腺与心包胸膜、左上肺紧密粘连转开胸手术。RATS组无中转开胸手术或延长手术切口长度的患者。两组患者均手术成功。RATS组手术时间显著短于VATS组(P<0.05)。两组术中出血量、48 h引流量、引流管留置时间比较差异无统计学意义(P>0.05)。两组术后VAS评分均呈下降趋势。RATS组术后第1天、第2天、第3天的VAS评分均低于VATS组,差异有统计学意义(P<0.05)。两组并发症发生率比较差异无统计学意义(5.88%vs 0.00%;P=0.525)。RATS组住院费用高于VATS组,差异有统计学意义(P<0.05)。两组术后住院时间比较差异无统计学意义(P>0.05)。结论RATS是治疗前纵隔病变安全可行的方法,相较于VATS,RATS对减少患者术后疼痛有积极意义,利于患者快速康复。

胸腔镜下肺段切除术治疗犬肺血管肉瘤

与传统手术方式相比,内窥镜手术对动物损伤较小,具有术后动物出血量少、疼痛轻、组织黏连少、恢复快等优点,已被广泛应用于国内外兽医临床。然而,胸腔镜手术因难度大、术后并发症多等在我国兽医临床较少实施。本文从病例基本情况、检查、诊断以及手术过程等方面,详细介绍了用胸腔镜成功为一例罹患肺转移性血管肉瘤的10岁金毛犬施行部分肺叶切除术的案例,并且分析了电视胸腔镜手术的设备器械选择、单肺气体插管方法,以及胸腔镜手术需要注意的一些细节,以期为同行开展兽医临床胸腔镜手术提供参考。

胸腔镜胸内固定术与传统开胸手术治疗多发肋骨骨折的疗效比较

目的探讨胸腔镜下胸内固定技术治疗多发肋骨骨折的临床疗效。方法回顾性比较我科2019年8月~2022年4月93例多发肋骨骨折的临床资料,按照手术方法分为胸腔镜组(n=50)和传统组(n=43)。胸腔镜组应用记忆合金肋骨接骨板行胸腔镜下胸腔内固定术,传统组应用记忆合金肋骨接骨板行传统开胸切开复位内固定术,比较2组患者手术时间、术中出血量、术后住院时间、术后带管时间、术后疼痛时间、术后引流量及术后并发症。结果胸腔镜组手术时间[(96.1±24.7)min vs.(110.2±29.1)min,t=-2.526,P=0.013]、术中出血量[(76.0±38.4)ml vs.(140.2±80.8)ml,t=-4.767,P=0.000]、术后带管时间[(3.9±1.6)d vs.(6.2±1.8)d,t=-2.739,P=0.008]、术后引流量[(132.4±53.9)ml vs.(157.9±50.5)ml,t=-2.345,P=0.021]、术后住院时间[(5.8±2.5)d vs.(9.7±2.5)d,t=-4.397,P=0.000]、疼痛时间[(4.9±1.2)d vs.(5.8±1.4)d,t=-2.199,P=0.030]显著短于/少于传统组。胸腔镜组术后肺炎、肺不张、胸腔积液发生率显著低于传统组(P<0.05)。术后1、3、12个月随访,肋骨接骨板固定牢靠,无一例移位、变形、脱落。结论胸腔镜下胸内固定术治疗多发肋骨骨折具有创伤小、疼痛轻,恢复快、临床效果确切等优点,值得临床推广。